Celltrion to supply breast cancer treatment Herzuma to Brazil

Celltrion’s breast cancer treatment ‘Herzuma’

South Korea’s Celltrion Inc. said Friday that it will supply its breast and metastatic gastric (stomach) cancer drug, Herzuma (trastuzumab), to Brazil for the next five years.

According to Celltrion, it won the supply bid from the Brazilian federal government. Through its Brazilian subsidiary, Celltrion will provide around 660,000 vials of Herzuma to Brazil over the next five years.

Celltrion has also agreed to deliver an extra 90,000 vials of its rheumatoid arthritis drug Remsima (infliximab) in response to an additional request from the Brazilian government earlier this year.